Article
Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells
2022-06-10
Abstract excerpt
<h4>Background: </h4> Androgen receptor variant 7 (AR-V7) is an important biomarker to guide treatment options for castration-resistant prostate cancer (CRPC) patients. Its detectability in circulating tumour cells (CTCs) opens non-invasive diagnostic avenues. While detectable at the transcript level, AR-V7 protein detection in CTCs may add additional information and clinical relevance. Aims The aim of this study...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 02886638-0dc8-5387-ad4e-f5f8d58030df
- DOI
- 10.21203/rs.3.rs-1602818/v2
